AI/ML InnovationsAIMLF +2.27% 3-Year RORE % is 6.45 as of Jan. 2026. The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, AI/ML Innovations ranks better than 57.43% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
AI/ML Innovations's 3-Year RORE % for the quarter that ended in Jan. 2026 was 6.45%.
The industry rank for AI/ML Innovations's 3-Year RORE % or its related term are showing as below:
AIMLF's 3-Year RORE % is ranked better than 57.43% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 0.195
vs AIMLF: 6.45
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
AI/ML Innovations 3-Year RORE % Related Terms
AI/ML Innovations 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for AI/ML Innovations's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIMLF vs VEEV, BTSG, TEM: 3-Year RORE % Comparison
For the Health Information Services subindustry, AI/ML Innovations's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AI/ML Innovations 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AI/ML Innovations's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where AI/ML Innovations's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jan. 2026 and 3-year before.
AI/ML Innovations (AIMLF) has a 3-Year RORE % of 6.45 as of Jan. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on AI/ML Innovations and its competitors. According to the industry distribution chart, AI/ML Innovations ranks #258 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 42.6%.
Is AI/ML Innovations' 3-Year RORE % too high?
AI/ML Innovations' current 3-Year RORE % is 6.45. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. AI/ML Innovations' value of 6.45 is 3207.7% above this industry median. Based on the distribution chart, AI/ML Innovations ranks #258 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does AI/ML Innovations' 3-Year RORE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, AI/ML Innovations ranks #258 out of 606 companies for 3-Year RORE %. This puts AI/ML Innovations in the upper half of its industry. The industry median 3-Year RORE % is 0.20. AI/ML Innovations' value of 6.45 is 3207.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AI/ML Innovations's current 3-Year RORE % of 6.45 is 3207.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on AI/ML Innovations and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AI/ML Innovations's current 3-Year RORE % is 6.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AI/ML Innovations stock overvalued right now?
Based on GuruFocus' analysis, AI/ML Innovations (AIMLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.03 — trading 206.8% above its estimated fair value. The current 3-Year RORE % is 6.45 and 3207.7% above the Healthcare Providers & Services industry median of 0.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For AI/ML Innovations (AIMLF), the current 3-Year RORE % is 6.45 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AI/ML Innovations Inc is a holding company. The company along with its subsidiaries is engaged in the research and development of health and wearable technologies, and the sale of licenses and consulting services related to those technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIMLF has been successfully added to your 